<div>
  <p>
  </p>
  <ul>
    <li>
      <p>
        Clinical trial technology provider Flatiron Health has teamed up with the Association of Cancer Care Centers (ACCC), a nationwide network of practitioners, to improve access to oncology-related clinical trials and refine the collection of clinical study data.
      </p>
    </li>
    <li>
      <p>
        The partnership will focus on researching clinical trials that are taking place at community oncology practices and also promoting the use of time-saving technology. Through the partnership, Flatiron Health will make its clinical trial data platform, Flatiron Clinical Pipe, available to the ACCN to accelerate research, pull trial data automatically from electronic health records, simplify data transfers, improve trial efficiency, and enhance patient access to oncology-focused trials.
      </p>
    </li>
    <li>
      <p>
        Through this collaboration, the collection and verification of trial data will be streamlined, ultimately benefiting patients on their path to accessing innovative therapies.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.mobihealthnews.com/news/exclusive-flatiron-health-association-cancer-care-centers-partner-clinical-trial-data">
      Mobi Health News
    </a>
  </p>
</div>


Clinical Trial Technology

PROMINENT_CATEGORY

<div>
 
<p>Flatiron Health, a provider of clinical trial technology, has partnered with the Association of Cancer Care Centers (ACCC), to enhance access to oncology-related clinical trials and refine the collection of clinical study data. The collaboration will concentrate on researching clinical trials happening at community oncology practices and promoting the use of technology that saves time. </p>
<p>Flatiron Health, as part of the partnership, will avail its clinical trial data platform, Flatiron Clinical Pipe, to the ACCN. This will speed up research, automate the pulling of trial data from electronic health records, simplify data transfers, improve trial efficiency, and boost patient access to oncology-focused trials.</p>
<p>The partnership is aimed at streamlining the collection and verification of trial data, ultimately benefitting patients in their journey towards accessing innovative therapies.</p>
 
</div>

Flatiron Health collaborates with ACCC to improve access to clinical trials

<div>
 
 <p>Triomics, a firm specializing in patient recruitment for oncology-related clinical trials, has raised USD 15 million in a venture funding round. The participating investors in the round included Lightspeed, Nexus Venture Partners, General Catalyst, and Y Combinator.</p>
 <p>The company intends to use the raised funds for the development of their platform and to expand their customer base. As of May 2024, the patient recruitment solution is in use by six cancer centers and hospitals, and the company aims to double this number by the end of the year.</p>
 <p>The firm has developed an AI-based platform called "OncoLLM", aimed at improving cancer care. The platform assists trial operators to recruit patients for clinical trials more efficiently, thereby preventing patient care delays, reducing backlogs and inefficiencies, and minimizing provider burnout. OncoLLM is designed to analyze unstructured oncology data, eliminating the need for manual data analysis and consequently improving patient-trial matching accuracy.</p>
 
</div>

Triomics raises USD 15 million in venture funding

<div>
 
 <p>Acclinate, a digital health company specializing in diversifying clinical trials, has successfully secured USD 17 million in a Series A funding round led by Cencora Ventures, with other investors' participation. This funding round brings the total capital raised by Acclinate to USD 23.5 million.</p>
 <p>The funds will be utilized to amplify the company’s mission of improving health equity and diversity in clinical trials.</p>
 <p>The company operates a community platform that assists healthcare organizations and pharmaceutical firms in their efforts to diversify clinical trials. The platform utilizes digital engagement tools and educational resources to increase participation from varied ethnic and racial groups. Acclinate's strategy leverages targeted outreach and advanced analytics to connect with underrepresented communities, supporting biotech and pharmaceutical firms in meeting their diversity targets within clinical trials.</p>
 
</div>

Acclinate raises USD 17 million in Series A funding to improve clinical trial diversity

<div>
 
 <p>PhaseV, a firm specializing in optimizing clinical trial design and analysis, has formed a partnership with Quanticate, a biometric contract research organization. The collaboration is aimed at enhancing the efficacy of adaptive clinical trials.</p>
 <p>The partnership will amalgamate Quanticate’s expertise in statistical programming, biostatistics, and clinical data management with PhaseV's machine learning software. The objective is to assess the applicability of an adaptive design in a proposed clinical trial, which allows modifications based on interim outcomes. The collaboration is aimed at resolving the difficulties encountered by sponsors in implementing adaptive trial designs effectively. Quanticate will be at the forefront in optimizing the trial design and management after determining its suitability.</p>
 
</div>

PhaseV partners with Quanticate to optimize adaptive clinical trials

<div>

 <p>Klineo, a clinical trials patient recruitment platform, has raised EUR 2 million in an investment round led by BPI France, with additional support from multiple individual investors.</p>
 <p>This funding will be used to broaden the company's operations and expand into new areas, including other pathologies and types of cancer. Klineo intends to include lung cancer in its short-term plans and aims to cover all cancer trials by the end of 2024. Expansion across Europe and the U.S., as well as the growth of the company team, will also be funded through this investment. </p>
 <p>Based in France, Klineo aids in patient recruitment for oncology-related clinical trials through an AI-based platform. This tool allows patients and their doctors to locate France-based clinical trials for skin and breast cancer treatments and lymphoma. As of April 2024, Klineo's platform is GDPR compliant and hosts user health data on ISO-certified Health Data Hosts, endorsed by the French Ministry of Health. Major pharmaceutical providers and research organizations such as Pfizer, AstraZeneca, and Lysarc support the company.</p>
 
</div>

Klineo raises EUR 2 million in funding to expand operations and coverage development

<div>
  
  <p>Biopharmaceutical company Parexel has teamed up with Palantir Technologies to enhance clinical trial processes through AI integration. The AI platforms of Palantir, Foundry and AIP, will be used to refine manual process, improve data discoverability, and extract insights. This is expected to augment efficiency, halve data collection time, save expert's time, and speed up the drug marketing process by providing a quicker and more comprehensive insight into trial performance.</p>
  <p>Palantir, a developer of multiple AI tools, offers solutions to streamline and optimize operations in multiple sectors. The company has four AI tools with distinct uses and offers boot camps for customers to comprehend and leverage their selected tool effectively. Among the four tools, AIP is particularly useful in clinical trials for its specific functions related to trial site selection protocols and workflows, thus aiding in efficient site selection, planning, and analysis.</p>
  
</div>

Parexel integrates Palantir's AI systems into clinical trial operations for streamlined insights

<div>

<p>Trialize, a provider of clinical trial technology, launched an open-source framework named the Trial Data Object Model (TDOM). This model is designed to boost interoperability amongst various e-clinical systems used in clinical research trials.</p>
<p>The primary goal of TDOM is to standardize the exchange of data between clinical systems, focusing especially on efficient, precise, and rapid data sharing. Key functions of this framework include developing a standard data model dedicated for clinical trials, constructing connectors for integration with existing data management systems, and ensuring enhanced clinical trial effectiveness through superior data management. The model is expected to simplify data management, preserve data integrity, and accelerate the development of medical treatments because of smoother research processes.</p>
<p>Trialize offers an AI-based and robotic process automation platform to aid in optimizing clinical trials and managing trial-related activities. Its decentralized trial platform assists clinical trial operators with various aspects of trials like recruitment, engagement, prescreening, monitoring, regulatory and compliance, data management, and collaboration. This platform can be customized as per individual needs of trial operators. While the company asserts that its platform can hasten trial timelines, improve data quality, and enhance patient engagement for pharmaceutical developers, the platform can also be used by contract research organizations, academic institutions, research centers, healthcare providers and clinics, regulatory agencies, ethics committees, and patients and patient advocacy groups.</p>

</div>

Trialize launches trial data object model for clinical trial interoperability

<div>

 <p>AI-based trial management platform provider, Cognivia, has successfully garnered a funding of EUR 15.5 million (USD 16.5 million) in its most recent round. Major participants in the funding round included Vesalius Biocapital IV, Société Fédérale de Participations et d'Investissement (SFPIM), and Wallonie Entreprendre (WE).</p>
 
 <p>Plans for the obtained funds are primarily geared towards the deployment of the company's AI and machine learning empowered predictive clinical trial solutions. These innovative solutions are designed to decipher the correlations between patient characteristics and behaviors on a global level.</p>

</div>

Cognivia raises EUR 15.5 million in funding to deploy company's AI and machine learning solutions

<div>
 <p>Flatiron Health, a company specializing in real-world data for cancer care, and the National Comprehensive Cancer Network (NCCN), an alliance of leading cancer centers, will continue their partnership aimed at improving cancer care and enhancing research. The collaboration primarily focuses on optimizing the use of real-world data for research purposes.</p>
 <p>The partnership will also focus on providing cancer centers across the nation with access to Flatiron's high-quality data for performance benchmarking and improvements. Both organizations will work together towards enhancing the quality of care through the development of new metrics and benchmarks to assess and measure the standard of cancer care provided.&nbsp;</p>
</div>

Flatiron Health renews collaboration with NCCN to improve cancer care

INCUMBENTS_PRESENT

<div>
 <p>IQVIA, an analytics, research and technology services provider, has extended its partnership with global cloud computing company Salesforce to foster the development of Salesforce's Life Sciences Cloud, which is a customer engagement platform for the global life sciences industry.</p>
 <p>IQVIA will make use of their Orchestrated Customer Engagement (OCE) platform that includes data and analytics capabilities alongside Salesforce's Customer Relationship Management (CRM) solutions to create a comprehensive engagement platform for life science companies. IQVIA plans to license its engagement platform and related software to Salesforce to aid the platform’s development, with an expected launch date for Salesforce Life Sciences Cloud set for 2025.</p>
</div>

All Updates

Flatiron Health collaborates with ACCC to improve access to clinical trials

Triomics raises USD 15 million in venture funding

Acclinate raises USD 17 million in Series A funding to improve clinical trial diversity

PhaseV partners with Quanticate to optimize adaptive clinical trials

Klineo raises EUR 2 million in funding to expand operations and coverage development

Parexel integrates Palantir's AI systems into clinical trial operations for streamlined insights

Trialize launches trial data object model for clinical trial interoperability

Cognivia raises EUR 15.5 million in funding to deploy company's AI and machine learning solutions

Flatiron Health renews collaboration with NCCN to improve cancer care

IQVIA expands partnership with Salesforce to develop customer engagement platform for life sciences

Clinical Trial Technology

Flatiron Health collaborates with ACCC to improve access to clinical trials

Contact us